2021
DOI: 10.3390/cells10040909
|View full text |Cite
|
Sign up to set email alerts
|

Antiretroviral Drugs Impact Autophagy with Toxic Outcomes

Abstract: Antiretroviral drugs have dramatically improved the morbidity and mortality of people living with HIV (PLWH). While current antiretroviral therapy (ART) regimens are generally well-tolerated, risks for side effects and toxicity remain as PLWH must take life-long medications. Antiretroviral drugs impact autophagy, an intracellular proteolytic process that eliminates debris and foreign material, provides nutrients for metabolism, and performs quality control to maintain cell homeostasis. Toxicity and adverse eve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 80 publications
(166 reference statements)
0
16
0
1
Order By: Relevance
“…Over 38 million people with HIV (PWH) are living worldwide [ 1 ]. HIV is treated with antiretroviral therapy (ART), which suppresses viral replication in infected cells but does not eradicate infection [ 2 ]. The ongoing presence of HIV in tissue reservoirs causes PWH to experience long-term comorbidities for which the underlying mechanisms are not extensively characterized [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…Over 38 million people with HIV (PWH) are living worldwide [ 1 ]. HIV is treated with antiretroviral therapy (ART), which suppresses viral replication in infected cells but does not eradicate infection [ 2 ]. The ongoing presence of HIV in tissue reservoirs causes PWH to experience long-term comorbidities for which the underlying mechanisms are not extensively characterized [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…ART alone also increased phagocytosis in both uninfected and HIV‐infected MDMs (Figure 1). We tested a combination of tenofovir, emtricitabine, and raltegravir because it represents a commonly prescribed regimen to treat HIV infection 9 . The off‐target effects in MDMs of these 3 drugs outside the context of HIV replication are not extensively characterized and may contribute to comorbidities associated with long‐term HIV infection.…”
Section: Discussionmentioning
confidence: 99%
“…The off‐target effects in MDMs of these 3 drugs outside the context of HIV replication are not extensively characterized and may contribute to comorbidities associated with long‐term HIV infection. Tenofovir and emtricitabine can inhibit DNA polymerase Ɣ, which helps replicate mitochondrial DNA 9 . This may cause downstream changes in metabolism that modify activation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The most well-studied type is macroautophagy, hereby termed autophagy, which can degrade cargo “in bulk” or selectively target specific cellular components for degradation [ 29 ]. In autophagy, a double-membraned organelle, the autophagosome (APG), forms and encloses around cytosolic cargo to be degraded [ 30 ]. During this process, Microtubule-associated Protein 1A/1B-Light Chain 3 (LC3) gets lipidated, forming LC3II, and associates with the inner and outer membrane of the forming APG, serving as a marker to monitor autophagic activity [ 31 ].…”
Section: Introductionmentioning
confidence: 99%